Common Contracts
3 similar Underwriting Agreement contracts by China Cord Blood Corp, Cell Therapeutics Inc
CHINA CORD BLOOD CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2009 • China Cord Blood Corp • Blank checks • New York
China Cord Blood Corporation, a Cayman Islands corporation (“Company”), confirms its agreement, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [*] shares of the Company’s ordinary shares, $0.0001 par value per share (the “Common Stock”), and, at the election of the Underwriters in the circumstances specified in Section 2 hereto, up to _____ additional shares of Common Stock. The ____ shares to be sold by the Company are herein called the “Firm Shares” and the _____ additional shares to be sold by the Company are herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriter elects to purchase pursuant to Section 2 hereof are herein collectively referred to as the “Securities.”
CHINA CORD BLOOD CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • October 29th, 2009 • China Cord Blood Corp • Blank checks • New York
China Cord Blood Corporation, a Cayman Islands corporation (“Company”), confirms its agreement, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [*] shares of the Company’s ordinary shares, $0.001 par value per share (the “Common Stock”), and, at the election of the Underwriters in the circumstances specified in Section 2 hereto, up to _____ additional shares of Common Stock. The ____ shares to be sold by the Company are herein called the “Firm Shares” and the _____ additional shares to be sold by the Company are herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriter elects to purchase pursuant to Section 2 hereof are herein collectively referred to as the “Securities.”
Underwriting AgreementUnderwriting Agreement • July 28th, 2009 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Cell Therapeutics, Inc., a Washington corporation (“Company”), confirms its agreement, subject to the terms and conditions stated herein, to issue and sell to Rodman & Renshaw, LLC (the “Underwriter”) an aggregate of 29,332,107 shares (the “Firm Shares”) of Common Stock, no par value per share (the “Common Stock”), and warrants (the “Firm Warrants” and together with the Firm Shares, the “Firm Securities”) to purchase an aggregate of 7,333,027 shares of Common Stock (the “Firm Warrant Shares”). The Firm Securities and the Optional Securities that the Underwriter elects to purchase pursuant to Section 2 are herein collectively referred to as the “Securities.”
